| Indicators | Browse All

Drugs Made In America Acquisition Corp. (DMAA)

Financial Services | Shell Companies | New York, United States | NasdaqGM
10.68 USD +0.02 (0.189%) ⇧ (July 13, 2026, 4 p.m. EDT)
After hours: 10.68 +0.01 (0.094%) ⇧ (July 13, 2026, 4 p.m. EDT)
Short-term:★★⯪☆☆Long-term:★★⯪☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | July 11, 2026, 5:55 a.m. EDT

The immediate catalyst here is the announced merger agreement with Power Analytics Global, which provides a clear path to value realization for this shell company. However, the investment thesis remains severely compromised by the company's precarious financial structure. The balance sheet is effectively insolvent, with a negative book value and a current ratio of just 0.03, indicating severe liquidity distress. Operating cash flows are deeply negative, and the entity carries debt significantly exceeding its cash reserves. While the stock trades near its trust value, suggesting the market prices in the upcoming de-SPAC, the underlying business quality is non-existent prior to the merger. There is no dividend income to offset the risks, and the lack of historical price data prevents any assessment of long-term performance trends. Consequently, while the merger offers a potential upside event, the current standalone entity represents a speculative bet on execution rather than a sound investment in a viable business.
Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.002007
AutoARIMA0.002040
AutoETS0.002052
MSTL_690.002518
MSTL_290.002727
MSTL_29_690.002879
AutoTheta0.005396

Forecast horizon: 60 days | Selected: MSTL

Forecast Reliability
Score 90%
H-stat 0.48
Ljung-Box p 0.000
Jarque-Bera p 0.458
Excess Kurtosis 0.56
Attribute Value
Sector Financial Services
Market Cap 259,277,424
Trailing P/E 53.40

Info Dump

Attribute Value
52 Week Change 0.043052793
Address1 420 Lexington Avenue
Address2 Suite 1402
All Time High 10.66
All Time Low 9.95
Ask 10.54
Ask Size 5
Average Daily Volume10 Day 70,400
Average Daily Volume3 Month 111,472
Average Volume 111,472
Average Volume10Days 70,400
Bid 10.63
Bid Size 1
Book Value -0.219
City New York
Country United States
Crypto Tradeable 0
Currency USD
Current Price 10.68
Current Ratio 0.03
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 10.68
Day Low 10.6589
Display Name Drugs Made In America
Earnings Growth 0.188
Earnings Quarterly Growth 0.571
Earnings Timestamp End 1,747,771,200
Earnings Timestamp Start 1,747,771,200
Ebitda Margins 0.0
Enterprise Value 360,184,192
Eps Trailing Twelve Months 0.2
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 10.612
Fifty Day Average Change 0.06799984
Fifty Day Average Change Percent 0.006407825
Fifty Two Week Change Percent 4.3052793
Fifty Two Week High 10.68
Fifty Two Week High Change 0.0
Fifty Two Week High Change Percent 0.0
Fifty Two Week Low 10.17
Fifty Two Week Low Change 0.5100002
Fifty Two Week Low Change Percent 0.050147515
Fifty Two Week Range 10.17 - 10.68
Financial Currency USD
First Trade Date Milliseconds 1,740,493,800,000
Float Shares 27,895,541
Full Exchange Name NasdaqGM
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.23568001
Held Percent Institutions 0.98230004
Implied Shares Outstanding 24,276,913
Industry Shell Companies
Industry Disp Shell Companies
Industry Key shell-companies
Ipo Expected Date 2,025-02-25
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Long Name Drugs Made In America Acquisition Corp.
Market us_market
Market Cap 259,277,424
Market State PREPRE
Max Age 86,400
Message Board Id finmb_1889535116
Most Recent Quarter 1,774,915,200
Net Income To Common 6,656,559
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 258,789,464
Open 10.66
Operating Cashflow -379,193
Operating Margins 0.0
Payout Ratio 0.0
Phone 646 726 7074
Post Market Change 0.010000229
Post Market Change Percent 0.09372286
Post Market Price 10.68
Post Market Time 1,783,972,803
Previous Close 10.6599
Price Hint 2
Price To Book -48.767124
Profit Margins 0.0
Quick Ratio 0.03
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.020100594
Regular Market Change Percent 0.18856269
Regular Market Day High 10.68
Regular Market Day Low 10.6589
Regular Market Day Range 10.6589 - 10.68
Regular Market Open 10.66
Regular Market Previous Close 10.6599
Regular Market Price 10.68
Regular Market Time 1,783,972,800
Regular Market Volume 4,457
Sand P52 Week Change 0.20847368
Sector Financial Services
Sector Disp Financial Services
Sector Key financial-services
Shares Outstanding 24,276,913
Shares Percent Shares Out 0.0034
Shares Short 82,989
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 86,950
Short Name Drugs Made In America Acquisiti
Short Percent Of Float 0.0042
Short Ratio 2.24
Source Interval 15
State NY
Symbol DMAA
Total Cash 14,887
Total Cash Per Share 0.0
Total Debt 100,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.2
Trailing P E 53.4
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 10.451435
Two Hundred Day Average Change 0.22856522
Two Hundred Day Average Change Percent 0.021869266
Type Disp Equity
Volume 4,457
Zip 10,170